Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New mouse model of Alzheimer’s, other diseases may clarify steps of brain degeneration

30.10.2003


A new mouse model developed by Harvard Medical School researchers and reported in the October 30 Neuron may allow scientists for the first time to spotlight two key proteins in a living animal and see how they contribute to the neuronal death and atrophy found in neurodegenerative diseases. The two proteins are dubbed p25 and cyclin-dependent kinase 5 (Cdk5).



"This is an excellent animal model for any therapeutic approach toward p25 and its link to Alzheimer’s and similar neurodegenerative diseases," says Li-Huei Tsai, HMS professor of pathology and Howard Hughes Medical Institute associate investigator, the study’s lead author. "We know that p25 causes neurodegeneration, and we want to figure out how that mechanism works."

The new model is the latest in Cdk5 research from the lab of Li-Huei Tsai. Over the past nine years, Tsai and her colleagues have defined many of Cdk5’s functions and noted the role its usual regulator p35 plays in orienting neuronal migration and growth. Their latest challenge is deciphering how Cdk5 and the pernicious regulator p25 lead to neurodegenerative diseases.


The protein p25 is usually not found in healthy brains, but is formed when a stroke or another oxygen-restricting event cuts p35--a beneficial protein found in healthy brains--to form p25, starting a domino effect that leads to neuronal death and malformation. Once present, p25 activates Cdk5 and alters its normally constructive behavior to kill neurons. To make matters worse, p25 is longer-lived than p35, so it accumulates in the brain and continues to keep Cdk5 active. Overactive Cdk5 and accumulated p25 have been noted in the brain tissue of people with the neurodegenerative diseases Alzheimer’s and Niemann–Pick type C. But the lack of a mouse model prevented researchers from demonstrating in vivo the effects of Cdk5 and p25 in the brain.

Tsai’s model exhibits the two characteristics researchers want to study: profound neuronal death and tau-associated degeneration. Some forms of the tau protein are associated with neurodegenerative diseases. In the model, Tsai turns on the production of p25 when the mice are mature. The mice were created with a gene that overproduces p25, but this gene is inhibited in the presence of the chemical doxycycline. The mice were conceived and raised for four to six weeks on doxycycline, which allowed their brains to develop normally. Once the mice were mature, Tsai turned on the p25 gene by removing doxycycline from their food.

Tsai’s model produces the results she expected. The mouse brains show a high accumulation of p25, substantial atrophy, progressive neuronal loss and tau pathology. After only 12 weeks of p25 exposure, the mouse brains were disintegrating, with a 40 percent decrease in neuronal density. By 30 weeks after p25 induction, the aggregation of tau proteins caused neurofibrillary tangles in the brain, a symptom of Alzheimer’s disease. The brains also showed neurodegeneration and neuronal cell death similar to earlier in vitro work.

Other labs have created mouse models that overproduce p25 throughout their lives, but these models fail to exhibit high brain cell p25 levels and neuronal death. Tsai explains that mice in these earlier models may have found a way to cope with the overexpression of toxic p25 during development, thereby lowering the accumulated p25 levels in their brains. These p25 levels may not have reached the threshold to induce the neuronal death and substantial tau pathology associated with aberrant p25. Without the high levels of accumulated p25 or evidence of neuronal death, these mice are not useful as models of neurodegeneration.

John Lacey | EurekAlert!
Further information:
http://www.hms.harvard.edu/
http://www.hms.harvard.edu/news/index.html

More articles from Life Sciences:

nachricht More genes are active in high-performance maize
19.01.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht How plants see light
19.01.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>